Drugs / WT1/PRAME vaccination
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02405338 | Mar 2015 → Nov 2019 | acute myeloid leukemia | MediGene | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WT1/PRAME vaccination | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02405338 ↗ |
| Modality | Vaccine | “WT1/PRAME autologous DC vaccine” NCT02405338 ↗ |